IL109094A0 - Human tnf muteins - Google Patents
Human tnf muteinsInfo
- Publication number
- IL109094A0 IL109094A0 IL10909494A IL10909494A IL109094A0 IL 109094 A0 IL109094 A0 IL 109094A0 IL 10909494 A IL10909494 A IL 10909494A IL 10909494 A IL10909494 A IL 10909494A IL 109094 A0 IL109094 A0 IL 109094A0
- Authority
- IL
- Israel
- Prior art keywords
- human tnf
- tnf muteins
- muteins
- human
- tnf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93810224 | 1993-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL109094A0 true IL109094A0 (en) | 1994-06-24 |
Family
ID=8214942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10909494A IL109094A0 (en) | 1993-03-29 | 1994-03-23 | Human tnf muteins |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5597899A (pt) |
| EP (1) | EP0619372A1 (pt) |
| JP (1) | JPH089976A (pt) |
| CN (1) | CN1099802A (pt) |
| AU (1) | AU5901994A (pt) |
| BR (1) | BR9401321A (pt) |
| CA (1) | CA2119089A1 (pt) |
| CZ (1) | CZ67694A3 (pt) |
| FI (1) | FI941459A7 (pt) |
| HU (1) | HUT68218A (pt) |
| IL (1) | IL109094A0 (pt) |
| NO (1) | NO941142L (pt) |
| NZ (1) | NZ260146A (pt) |
| RU (1) | RU94009852A (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA24169A1 (fr) * | 1996-05-08 | 1997-12-31 | Hoffmann La Roche | Traitement de l'asthme a l'aide de la tnfr-ig |
| EE9900461A (et) | 1997-04-15 | 2000-06-15 | Farmaceutisk Laboratorium Ferring A/S | Modifitseeritud TNFa molekulid, neid kodeeriv DNA ning selliseid TNFa molekule ja DNA sisaldavad vaktsiinid |
| CN1062274C (zh) * | 1997-10-07 | 2001-02-21 | 复旦大学 | 人肿瘤坏死因子α衍生物及其制备方法 |
| US6354297B1 (en) * | 1998-04-16 | 2002-03-12 | The Uniformed Services University Of The Health Sciences | Method and device for destroying fat cells by induction of programmed cell death |
| US6620382B1 (en) * | 1998-05-22 | 2003-09-16 | Biopheresis Technologies, Llc. | Method and compositions for treatment of cancers |
| US8197430B1 (en) | 1998-05-22 | 2012-06-12 | Biopheresis Technologies, Inc. | Method and system to remove cytokine inhibitor in patients |
| US20020077276A1 (en) * | 1999-04-27 | 2002-06-20 | Fredeking Terry M. | Compositions and methods for treating hemorrhagic virus infections and other disorders |
| US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
| US7687461B2 (en) * | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
| US7662367B2 (en) * | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
| US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
| US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
| US20070172449A1 (en) * | 2000-03-02 | 2007-07-26 | Xencor, Inc. | TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
| US7244823B2 (en) * | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
| US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
| US20030166559A1 (en) * | 2002-01-04 | 2003-09-04 | Desjarlais John R. | Dominant negative proteins and methods thereof |
| US7179891B2 (en) * | 2002-03-25 | 2007-02-20 | Tadanori Mayumi | Physiologically active complex |
| JP4177604B2 (ja) * | 2002-03-25 | 2008-11-05 | 株式会社林原生物化学研究所 | 生理活性複合体 |
| EP1578799B8 (en) * | 2002-12-02 | 2011-03-23 | Amgen Fremont Inc. | Antibodies directed to tumor necrosis factor and uses thereof |
| GEP20084487B (en) * | 2002-12-26 | 2008-09-25 | Mountain View Pharmaceuticals | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof |
| US7642340B2 (en) * | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
| AU2004279895A1 (en) | 2003-10-10 | 2005-04-21 | Xencor, Inc | Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders |
| TW200526780A (en) * | 2004-01-06 | 2005-08-16 | Hayashibara Biochem Lab | TNF antagonists and TNF inhibitors comprising the same as the active ingredient |
| PL1949915T3 (pl) * | 2004-04-30 | 2013-04-30 | Biopheresis Tech Inc | Sposób i układ do usuwania rozpuszczalnych TNFR1, TNFR2 i IL2R u pacjentów |
| GB0425972D0 (en) | 2004-11-25 | 2004-12-29 | Celltech R&D Ltd | Biological products |
| US20070065514A1 (en) * | 2005-09-22 | 2007-03-22 | Howell Mark D | Method for enhancing immune responses in mammals |
| US20080075690A1 (en) * | 2006-09-22 | 2008-03-27 | Mark Douglas Howell | Method for enhancing immune responses in mammals |
| WO2008127515A1 (en) * | 2007-03-01 | 2008-10-23 | Cytologic, Inc. | Compositions and method for enhancing immune responses in mammals |
| GB201510758D0 (en) | 2015-06-18 | 2015-08-05 | Ucb Biopharma Sprl | Novel TNFa structure for use in therapy |
| CN106540252B (zh) * | 2016-12-07 | 2020-04-28 | 四川大学 | 针对肿瘤坏死因子α的蛋白疫苗及其用途 |
| GB201621907D0 (en) | 2016-12-21 | 2017-02-01 | Ucb Biopharma Sprl And Sanofi | Antibody epitope |
| WO2018185247A1 (en) * | 2017-04-06 | 2018-10-11 | Universität Stuttgart | Tumor necrosis factor receptor (tnfr) binding protein complex with improved binding and bioactivity |
| WO2020260368A1 (en) | 2019-06-24 | 2020-12-30 | Universität Stuttgart | Tnfr2 agonists with improved stability |
| KR20240035998A (ko) | 2021-06-17 | 2024-03-19 | 이뮤니컴 인코포레이티드 | 포획 리간드로서의 변형된 tnf |
| AR133963A1 (es) * | 2023-09-29 | 2025-11-19 | Trex Bio Inc | MOLÉCULAS DE FUSIÓN VARIANTE TNF-a |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| DE3582183D1 (de) * | 1984-03-06 | 1991-04-25 | Dainippon Pharmaceutical Co | Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid. |
| US4650674A (en) * | 1984-07-05 | 1987-03-17 | Genentech, Inc. | Synergistic cytotoxic composition |
| GR851626B (pt) * | 1984-07-05 | 1985-11-26 | Genentech Inc | |
| DE3750056T2 (de) * | 1986-06-20 | 1995-04-06 | Dainippon Pharmaceutical Co | Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS. |
| JPH07106158B2 (ja) * | 1986-12-04 | 1995-11-15 | サントリー株式会社 | 抗腫瘍活性を有する新規ポリペプチドおよびその製造法 |
| WO1988006625A2 (en) * | 1987-02-26 | 1988-09-07 | Cetus Corporation | Arginine-depleted human tumor necrosis factor |
| DE3843534A1 (de) * | 1988-12-23 | 1990-07-12 | Basf Ag | Neue tnf-polypeptide |
| CA2055168A1 (en) * | 1990-11-21 | 1992-05-22 | Walter Fiers | Tnf-muteins |
| IL99120A0 (en) * | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
| SK376492A3 (en) * | 1992-04-02 | 1995-06-07 | Hoffmann La Roche | Tnf - muteins and method of their production |
-
1994
- 1994-03-15 CA CA002119089A patent/CA2119089A1/en not_active Abandoned
- 1994-03-17 EP EP94104154A patent/EP0619372A1/en not_active Withdrawn
- 1994-03-22 NZ NZ260146A patent/NZ260146A/en unknown
- 1994-03-23 IL IL10909494A patent/IL109094A0/xx unknown
- 1994-03-23 CZ CZ94676A patent/CZ67694A3/cs unknown
- 1994-03-23 HU HU9400829A patent/HUT68218A/hu unknown
- 1994-03-23 AU AU59019/94A patent/AU5901994A/en not_active Abandoned
- 1994-03-24 US US08/217,529 patent/US5597899A/en not_active Expired - Fee Related
- 1994-03-24 RU RU94009852/13A patent/RU94009852A/ru unknown
- 1994-03-28 BR BR9401321A patent/BR9401321A/pt not_active Application Discontinuation
- 1994-03-28 CN CN94103792A patent/CN1099802A/zh active Pending
- 1994-03-28 NO NO941142A patent/NO941142L/no unknown
- 1994-03-29 JP JP6059514A patent/JPH089976A/ja active Pending
- 1994-03-29 FI FI941459A patent/FI941459A7/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9400829D0 (en) | 1994-06-28 |
| BR9401321A (pt) | 1994-10-18 |
| NZ260146A (en) | 1995-10-26 |
| CZ67694A3 (en) | 1995-02-15 |
| NO941142D0 (no) | 1994-03-28 |
| US5597899A (en) | 1997-01-28 |
| AU5901994A (en) | 1994-10-06 |
| FI941459A0 (fi) | 1994-03-29 |
| EP0619372A1 (en) | 1994-10-12 |
| CA2119089A1 (en) | 1994-09-30 |
| NO941142L (no) | 1994-09-30 |
| RU94009852A (ru) | 1996-07-20 |
| JPH089976A (ja) | 1996-01-16 |
| CN1099802A (zh) | 1995-03-08 |
| HUT68218A (en) | 1995-06-28 |
| FI941459A7 (fi) | 1994-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL109094A0 (en) | Human tnf muteins | |
| IL106732A0 (en) | Human interleukin-13 | |
| ZA936097B (en) | Human interleukin-13 | |
| AU121085S (en) | Chair | |
| SG42865A1 (en) | Therapeutic compositions and methods | |
| AU121086S (en) | Chair | |
| AU119673S (en) | Chair | |
| AU120796S (en) | Chair | |
| GB9312204D0 (en) | Therapeutic composition | |
| GB9307013D0 (en) | Therapeutic combinations | |
| ZA946217B (en) | Therapeutic combination | |
| EP0797592A4 (en) | HUMAN STANNIOCALCIN ALPHA | |
| HU9200644D0 (en) | Medical preparatives | |
| GB2292219B (en) | Polymorphisms in human phosphoglucomutase-1 | |
| GB9305316D0 (en) | Skin emollinets | |
| ZA947865B (en) | Human glactokinase | |
| EP0795006A4 (en) | HUMAN MuT2 | |
| IL97169A0 (en) | Skin gel | |
| GB9306646D0 (en) | Therapeutic agetns | |
| GB9308962D0 (en) | Therapeutic agetns | |
| GB9302197D0 (en) | Non-invasive bilirubinometer | |
| HU9201252D0 (en) | Medical filtering-diagnosticizing unit | |
| GB9210576D0 (en) | Medical use | |
| GB9210594D0 (en) | Medical use | |
| GB9210595D0 (en) | Medical use |